Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention

Circulation

Volumn 117, Issue 24, 2008, Pages 3152-3156

  Jaffe, Ronen ^a,b   Charron, Thierry ^b   Puley, Geoffrey ^b   Dick, Alexander ^a   Strauss, Bradley H ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADENOSINE; ADRENALIN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FIBRINOGEN RECEPTOR ANTAGONIST; NICORANDIL; NITROPRUSSIDE SODIUM; VERAPAMIL;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MICROVASCULAR ISCHEMIA; NO REFLOW PHENOMENON; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SAPHENOUS VEIN; ST SEGMENT; THROMBOSIS; AGED; CASE REPORT; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHY; HEART FAILURE; MALE; MICROCIRCULATION; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIAL OCCLUSIVE DISEASES; CORONARY CIRCULATION; CORONARY VESSELS; DIABETIC ANGIOPATHIES; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 48249115694     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.742312     Document Type: Article

References (14)

1. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angio-plasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202-1209.
2. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, Safian RD. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol. 1995;75:778-782.
3. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negoro S, Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-1999.
4. Bonz AW, Lengenfelder B, Strotmann J, Held S, Turschner O, Harre K, Wacker C, Waller C, Kochsiek N, Meesmann M, Neyses L, Schanzenbacher P, Ertl G, Voelker W. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol. 2002;40:662-668.
5. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC; Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341: 1949-1956.
6. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, Choussat R, Pinton P. Platelet glycoprotein Ilb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895-1903.
7. Sezer M, Oflaz H, Goren T, Okcular I, Umman B, Nisanci Y, Bilge AK, Sanli Y, Meric M, Umman S. Intracoronary strep-tokinase after primary percutaneous coronary intervention. N Engl J Med. 2007; 356:1823-1834.
8. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358: 557-567.
9. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schul-theiss HP, Dulas D, Rutherford BD, Anto-niucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcircu-latory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293: 1063-1072.
10. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postcondi-tioning. Cardiovasc Res. 2006;70:240-253.
11. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nic-orandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005;112:1284-1288.
12. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M. Long-term benefit of postconditioning. Circulation. 2008;117:1037-1044.
13. Bairn DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-1290.
14. Blankenship JC, Tasissa G, O'Shea JC, Iliadis EA, Bachour FA, Cohen DJ, Lui HK, Mann T III, Cohen E, Tcheng JE. Effect of glycoprotein Ilb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J Am Coll Cardiol. 2001;38:653-658.